Tevogen Bio Inc.

NASDAQ: TVGN · Real-Time Price · USD
0.96
0.01 (1.23%)
At close: Aug 18, 2025, 3:59 PM
0.98
1.83%
After-hours: Aug 18, 2025, 07:47 PM EDT

Tevogen Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
1.28M 8.84K 129.19K 7.12M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a 16.68M 356.86M 351.92M
Other Long-Term Assets
575.84K n/a -1.31M -351.57M
Receivables
158.82K 344.5K n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
919.09K 2.5K 145.17K 53.96K
Total Current Assets
2.36M 355.84K 274.36K 7.17M
Property-Plant & Equipment
524.93K n/a 1.31M 142.62K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
1.1M 16.68M 356.86M 485.27K
Total Assets
3.46M 17.04M 357.14M 7.66M
Account Payables
5.2M 1.14M 210.45K 378K
Deferred Revenue
n/a n/a -375.81K n/a
Short-Term Debt
1.88M 1.63M n/a n/a
Other Current Liabilities
403.23K -92.39K -856.98K 45.27K
Total Current Liabilities
9.04M 3M 350.45K 667.94K
Long-Term Debt
1M n/a 39.3M 23.48M
Other Long-Term Liabilities
87.18K 14.49M -25.02M n/a
Total Long-Term Liabilities
1.09M 14.73M 14.71M 23.48M
Total Liabilities
10.14M 17.73M 15.06M 24.15M
Total Debt
2.89M 1.63M 40.01M 23.48M
Common Stock
17.8K 16.68M 356.87M 63.88K
Retained Earnings
-113.39M -17.38M -14.78M -17.14M
Comprehensive Income
n/a n/a -0.00 n/a
Shareholders Equity
-6.67M -695.8K 342.08M -16.49M
Total Investments
n/a 16.68M 356.86M 351.92M